Kennedy Schaal is the CEO of Rejuve.bio, a biotech company with the goal of solving aging by building AGI for drug discovery.SummaryIn this episode, Kennedy Schaal introduces her company Rejuve.bio which comes out of the SingularityNet. Kennedy Schaal and I discuss the intersection of data, AI, and collaboration in the longevity sector. We explore the importance of community engagement, the potential for shared data to advance research, and the role of marketing in promoting longevity initiatives. Kennedy emphasizes the need for a collective approach to solving aging-related issues and shares her personal commitment to community service and the arts.Links- ⁠⁠⁠⁠⁠⁠⁠Zelar City Website⁠⁠⁠⁠⁠⁠⁠- ⁠⁠⁠⁠⁠⁠⁠What is Zelar City?⁠⁠⁠- ⁠Rejuve.bio- ⁠This episode on YouTubeChapters